Top compounds associated with response to RP11-134F2.8


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.033 0.3
mRNA erismodegib CTRPv2 pan-cancer AAC 0.038 0.3
mRNA DBeQ CTRPv2 pan-cancer AAC -0.037 0.3
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.047 0.3
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.033 0.3
mRNA Platin CTRPv2 pan-cancer AAC 0.037 0.3
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.035 0.3
mRNA CIL70 CTRPv2 pan-cancer AAC -0.048 0.3
mRNA MI-2 CTRPv2 pan-cancer AAC -0.052 0.3
Download CSV